Catalyst Wire Dossier Catalyst Wire Dossier

Marketed ocular anti-allergy medication 2

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Marketed ocular anti-allergy medication 2, covering 2009-05-27 to 2009-05-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis [Phase 4]

See pricing